Montevideo |

Researchers at the University of the Republic (Udelar) of Uruguay are studying the medicinal properties of cannabis and preparing the inclusion of a specific discipline on the subject to be integrated into the curriculum of the medical course starting next year.

This team looks to see the benefits of the components of marijuana in treating pain, nausea and vomiting, epilepsy, Parkinson's, lack of appetite, anorexia caused by chemotherapy or in patients with HIV, and other diseases and symptoms in addition to finding possible hexes.

My son Wiley suffered from infantile spasms, a type of refractory seizure. Through the use of Cannabidiol (CBD) rich cannabis oil we cured his epilepsy outright. Since that time his energy has doubled, his development has blossomed, and I get to see just how a toddler should be. Wiley is running and playing, tearing up the house faster than I can fix it. 

CNN’s medical correspondent Dr. Sanjay Gupta says medical marijuana should be legalized — period. In his third special on the subject, “Weed 3: The Marijuana Revolution,” he calls for all healthcare providers to re-evaluate their stance on this natural therapy, in light of the latest science.

According to Dr. Gupta:1

“There is now promising research into the use of marijuana that could impact tens of thousands of children and adults, including treatment for cancer, epilepsy, and Alzheimer's, to name just a few.

The success and benefits of medical marijuana. Follow up on parents whose children suffer from up to 100 epileptic seizures per day if they’re on conventional anti-convulsion medication, but have zero seizures when treated with medical marijuana (dried medical marijuana extracts, in these cases, marijuana oil).  Also, medical researcher engaged in studying the benefits of CBD, parent Alex Repetski returns and is joined by  Dr. Mac Burnham.

I’ll be the first to have a parent and a doctor or research physician on air.

Guests:  Alexander Repetski. One of the parents last Sunday.  His three year old daughter is completely free of seizures with marijuana oil.

And

Denver health officials have issued a food safety advisory for RX Green's "Autopilot" capsules, a marijuana-infused product.

The city's health department says any of the manufacturer's Omega-3 and THC pills made before Sept. 17 should be discarded. The products have a license number of 404R-00109 on their package.

"The advisory is due to concerns regarding the manufacturing process and lack of temperature controls in place to prevent bacterial growth," Denver's Department of Environmental Health said in an advisory on Friday. "There have been no reports of illness at this time."

"This advisory has been issued as a result of a food safety inspection."

The health department says RX Green, based in Aspen, has not issued a recall.

Nearly 90 days since medical cannabis became legal to sell in Minnesota, the young industry is working through some growing pains. While a number of patients express vast improvements in their quality of life after using cannabis, others complain of high costs and trouble getting the drug.

So far, the state has registered 518 patients and 404 health care practitioners. The most common condition among those patients is muscle spasms, followed by seizures and cancer.

But not all approved patients have actually purchased medical cannabis.

Rep. Pat Garofalo, R-Farmington, who sits on the Minnesota Medical Cannabis Task Force, said the law has created even more hurdles for patients suffering from chronic conditions.

Researchers at the University of Bristol, UK, have carried out an analysis of dozens of trials of the medical benefits of cannabis or marijuana.

Dr. Penny Whiting and her team looked at 79 randomized trials including 6,462 participants. Overall, this contained “moderate-quality evidence” to support the use of cannabinoids (chemical compounds that are the active principles in cannabis or marijuana) for chronic pain or spasticity due to multiple sclerosis.

There is not yet enough clinical evidence suggesting that cannabis is effective for self-management of pain. Some short-duration trials have shown efficacy, whereas other studies have shown little improvement over placebo. Effective or not, however, cannabis continues to be widely used as a self-management strategy by patients with a wide range of symptoms and diseases. A study in The Journal of Pain suggests that such use over a one-year period did not increase patients’ risk of serious adverse events. This was a prospective cohort study in Canada to describe safety issues among subjects with chronic non-cancer pain, with a participant base of 216 individuals with chronic pain. A standardized herbal cannabis product (12.5% THC) was dispensed to eligible subjects for one year.